Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Cash from Operations (2016 - 2025)

Apyx Medical (APYX) has disclosed Cash from Operations for 15 consecutive years, with 2530000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 13.86% year-over-year to 2530000.0, compared with a TTM value of 8001000.0 through Dec 2025, up 55.67%, and an annual FY2025 reading of 8001000.0, up 55.67% over the prior year.
  • Cash from Operations was 2530000.0 for Q4 2025 at Apyx Medical, up from 3536000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 3696000.0 in Q3 2023 and bottomed at 6341000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 3101300.0, with a median of 3570500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations crashed 2216.82% in 2022, then surged 168.96% in 2023.
  • Year by year, Cash from Operations stood at 214000.0 in 2021, then plummeted by 2216.82% to 4530000.0 in 2022, then soared by 51.17% to 2212000.0 in 2023, then plummeted by 32.78% to 2937000.0 in 2024, then rose by 13.86% to 2530000.0 in 2025.
  • Business Quant data shows Cash from Operations for APYX at 2530000.0 in Q4 2025, 3536000.0 in Q3 2025, and 1233000.0 in Q2 2025.